Norlignans, acylphloroglucinols, and a dimeric xanthone from Hypericum chinense

Area of Science:

• Phytochemistry
• Natural Products Chemistry
• Medicinal Chemistry

Background:

• Natural products are a rich source of novel bioactive compounds.
• Hypericum chinense is a plant species with potential medicinal properties.
• Multidrug-resistant (MDR) bacteria pose a significant global health threat.

Purpose of the Study:

• To isolate and characterize new chemical constituents from Hypericum chinense.
• To evaluate the antibacterial activity of isolated compounds against MDR strains.
• To identify potential leads for new antibacterial drug development.

Main Methods:

• Phytochemical investigation involving isolation and structure elucidation using spectroscopic analysis (NMR, MS).
• Antibacterial assays were performed against a panel of MDR bacterial strains, including Staphylococcus aureus SA-1199B.
• Minimum Inhibitory Concentration (MIC) values were determined for active compounds.

Main Results:

• Two new norlignans (hyperiones A and B) and three new acylphloroglucinols (aspidinol C, hyperaspidinols A and B) were identified.
• The known compounds aspidinol D and hyperidixanthone were also isolated.
• Aspidinol C and aspidinol D exhibited promising activity against MDR Staphylococcus aureus SA-1199B, with MICs of 2 μg/mL and 4 μg/mL, respectively.

Conclusions:

• Hypericum chinense is a source of novel bioactive compounds.
• Aspidinol C and aspidinol D demonstrate significant antibacterial potential against MDR Staphylococcus aureus.
• These compounds may serve as valuable leads for developing new therapeutic agents against resistant bacterial infections.